MELK (Maternal embryonic leucine-zipper kinase)/FoxM1(Forkhead box M1) signaling is estimated to be up-regulated in various cancers and associated with tumor growth, metastasis, angiogenesis and chemoresistance (Joshi et al., 2013; Kim et al., 2015). This evidence concerns the gene FOXM1 and cancer.